These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3613336

  • 1. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 3. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F.
    Prog Clin Biol Res; 1988 Oct; 260():599-602. PubMed ID: 3362909
    [No Abstract] [Full Text] [Related]

  • 4. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA, de la Peña JJ, Hidalgo L, Cisneros J, Jiménez de León J, Machuca J.
    Arch Esp Urol; 1986 Oct; 39(1):33-46. PubMed ID: 3707210
    [No Abstract] [Full Text] [Related]

  • 5. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y, Ogawa T, Yoshida T, Yamamoto S, Hirano A, Watanabe T, Shinka T, Ohkawa T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [Abstract] [Full Text] [Related]

  • 6. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F, Chrétien Y, Vallantin X, Collet C, Lachand AT, Dufour B.
    Ann Urol (Paris); 1988 Aug; 22(3):216-9. PubMed ID: 3401004
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 8. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 9. Pre surgery chemotherapy in bladder cancer.
    Francini M, Veronesi A, Dal Bo V, Carbone A, Monfardini S.
    Prog Clin Biol Res; 1988 Feb; 260():585-9. PubMed ID: 3362908
    [No Abstract] [Full Text] [Related]

  • 10. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y, Yoshida K.
    Hinyokika Kiyo; 1999 Feb; 45(2):149-53. PubMed ID: 10212791
    [Abstract] [Full Text] [Related]

  • 11. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder.
    Lynch DF.
    Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T.
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract] [Full Text] [Related]

  • 13. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H, Tokumitsu M, Morikawa M, Numata A, Yachiku S, Iuchi H, Yamauchi K.
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract] [Full Text] [Related]

  • 14. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
    Bittard H.
    J Urol (Paris); 1988 Jun; 94(7):345-7. PubMed ID: 2464650
    [Abstract] [Full Text] [Related]

  • 15. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K, Nakame Y, Horiuchi S, Kaneoya F, Kuroda T, Tanoiri A, Koizumi M, Takahashi M, Negishi T, Saitoh H.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract] [Full Text] [Related]

  • 16. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T, Washizuka M, Kihara K, Takahashi T, Sakata Y, Tai K, Nagayama T, Okada K, Kusuyama H, Ishii Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb 20; 22(1):40-6. PubMed ID: 3611890
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.